Respiratory syncytial virus (RSV) infection can be harmful, especially in infants and the elderly (with chronic heart diseases), even though most individuals recover in a week or two.
- There is currently no cure for respiratory syncytial virus (RSV) infection. Scientists, on the other hand, are still learning more about the virus and looking for strategies to prevent infection or better manage severe sickness.
- Palivizumab (Synagis), which is given as a shot (injection), can help prevent certain infants and toddlers aged 2 and under who are at high risk of significant RSV complications.
- Ribavirin is approved for the treatment of severe respiratory syncytial virus (RSV) infection.
- The initial injection is given at the start of the respiratory syncytial virus (RSV) infection, and subsequent injections are given on a monthly basis throughout the season.
- This drug only works to keep respiratory syncytial virus (RSV) infection from infecting you. It doesn't help with treatment after symptoms appear.
- Consult your child's doctor to see if you can give Palivizumab to your child and to learn more about it.
- The above-mentioned medications need to be used under the supervision of doctors only.